Financial Year |
March 31 2023 |
Monetary Funds |
70,302,361.42 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
103,679,953.04 |
Accounts Receivable |
260,264,636.54 |
Advances to Suppliers |
52,591,004.42 |
Other Receivables |
2,570,183.86 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
348,757,894.30 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
36,110,780.24 |
Total Current Assets |
905,103,529.50 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
11,606,470.54 |
Fixed Assetes |
1,225,675,809.61 |
Under-construction Projects |
317,478,339.68 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
103,381,558.33 |
R&D expenses |
-- |
Goodwill |
33,204,238.92 |
Long-Term Deferred and Prepaid Expenses |
2,779,535.39 |
Deferred Income Tax Assets |
53,320,208.92 |
Other Non-Current Assets |
33,536,310.22 |
Sub-Total of Non-Current Assets |
1,783,545,995.02 |
Total Assets |
2,688,649,524.52 |
Short-Term Loans |
675,315,362.62 |
Trading Financial liabilities |
-- |
Notes Payable |
144,831,935.16 |
Accounts Payable |
266,171,805.02 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
9,396,380.27 |
Taxes Payable |
7,326,230.56 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
21,877,741.75 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
211,353,678.55 |
Other Current Liabilities |
47,420,990.37 |
Sub-Total of Current Liabilities |
1,407,226,444.60 |
Long-term Loans |
252,729,548.82 |
Bonds Payable |
137,355,461.63 |
Long-Term Accounts Payable |
12,259,919.90 |
Special Payable |
-- |
Estimatied Liabilities |
1,867,612.12 |
Deferred Income Tax Liabilities |
8,322,099.34 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
482,465,981.32 |
Total Liabilities |
1,889,692,425.92 |
Paid-In Capital(Or Share Stock) |
318,441,723.00 |
Capital Surplus |
158,125,189.88 |
Surplus Reserve |
39,755,180.14 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
229,844,896.06 |
Minority Stockholder's Interest |
11,137,840.11 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
787,819,258.49 |
Owner's Equity(Stockholder's Equity) |
798,957,098.60 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,688,649,524.52 |